“…Corialactones have been found in terrestrial Himalayan shrubs ( Coriaria nepalensis ) that have been used as a Chinese herbal medicine for the treatment of numbness, toothache, traumatic injury, and acute conjunctivitis, among other ailments . Notably, two sesquiterpenes identified from this terrestrial source have been claimed to be clinically useful for the treatment of schizophrenia. , Despite the structural similarity of corialactone sesquiterpene natural products to the potent GABA antagonist picrotoxinin (described as one of the most toxic agents of plant origin) and the modestly analgesic alkaloid dendrobine (Figure B), , sesquiterpenes from the roots of Coriaria nepalensis appear to have a unique and nontoxic pharmacological profile in vitro at concentrations up to 10 μM [PC-12 (neuro), HCT-8 (colon), HepG2 (liver), BGC-823 (gastric), A549 (lung epithelia), and SKOV3 (ovarian) - MTT assays] . Piquing our interest in corialactones as synthetic targets, glycosides of sesquiterpenes in this class, as well as semisynthetic variants ( 1 – 3 ; Figure A), have been reported as neurotrophic agents, despite a variable nature of C14 (i.e., active agents are reported that contain an allylic alcohol, allylic halide, or an electrophilic enone in this region of the natural product structure) .…”